MedPath

Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

Phase 1
Completed
Conditions
Skin Graft
Interventions
Other: Standard dressings
Biological: Autologous Platelet Rich Plasma
Biological: Keratinocyte suspension
Registration Number
NCT00856934
Lead Sponsor
Centre Hospitalier Universitaire Vaudois
Brief Summary

This prospective randomized trial evaluated the impact of autologous keratinocytes suspended in platelet concentrates on healing skin graft donor site wounds. It was hypothesized that the treatment would speed and improve wound healing.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Skin graft donor sites total surface < 15% BSA
  • Skin graft donor site size: 0.2mm deep, 30 to 40 cm2 surface area
Exclusion Criteria
  • Patients treated with immunosuppressors
  • Patients treated with corticoids
  • Patients suffering from terminal renal insufficiency
  • Patients suffering from severe peripheral arteriopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlStandard dressingsWounds covered with standard dressings: three layers of paraffin gauze, standard bandages, elastic bandage.
PRPAutologous Platelet Rich PlasmaPRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
PRPStandard dressingsPRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
PRP+KAutologous Platelet Rich PlasmaKeratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
PRP+KKeratinocyte suspensionKeratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
PRP+KStandard dressingsKeratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
Primary Outcome Measures
NameTimeMethod
Complete Wound HealingPost operative day 5 and every other day thereafter

Time required for complete epithelialization in days

Secondary Outcome Measures
NameTimeMethod
PainPost operative day 5

Pain evaluated on a Visual Analog Scale (VAS) from 0 (no pain) to 10 (extreme pain), specifically during dressing replacement.

Trial Locations

Locations (1)

Centre hospitalier Universitaire Vaudois

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath